Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Retinoic acid reduces cell damage from oxidative stress.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Using minoxidil with tocopherol acetate in ethosomes improves hair regrowth in hair loss treatment.

The new compound may be a safer alternative to finasteride for prostate protection.